Understanding sexual health and prevention among women in Alabama
CAMELLIA Cohort: A longitudinal study to understand sexual health and prevention among women in Alabama
This study is looking at the sexual health and HIV prevention needs of women in Alabama, especially Black women, to better understand their challenges and improve access to helpful resources like PrEP, a medication that can prevent HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10908368 on NIH RePORTER |
What this research studies
This research investigates the sexual health and HIV prevention needs of women in Alabama, particularly focusing on the disparities faced by Black women. It aims to establish a cohort of cis- and trans-gender women at risk for HIV, using a population-based approach to gather data on factors influencing STI and HIV diagnosis and predictors for PrEP use. The study will refine a digital platform to deliver interventions aimed at improving awareness and access to HIV prevention tools. By understanding these dynamics, the research seeks to enhance the effectiveness of HIV prevention strategies in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research include cis- and trans-gender women in Alabama who are at risk for HIV, especially those with recent STI diagnoses.
Not a fit: Patients who are not at risk for HIV or who do not reside in Alabama may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to HIV prevention methods for women in Alabama, particularly those from marginalized communities.
How similar studies have performed: Previous research has shown success in utilizing digital platforms for HIV prevention, indicating that this approach has potential for positive outcomes.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Elopre, Latesha Ellen — University of Alabama at Birmingham
- Study coordinator: Elopre, Latesha Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.